These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 37397366

  • 21. Integrin-linked kinase activity regulates Rac- and Cdc42-mediated actin cytoskeleton reorganization via alpha-PIX.
    Filipenko NR, Attwell S, Roskelley C, Dedhar S.
    Oncogene; 2005 Sep 01; 24(38):5837-49. PubMed ID: 15897874
    [Abstract] [Full Text] [Related]

  • 22. Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells.
    Azios NG, Krishnamoorthy L, Harris M, Cubano LA, Cammer M, Dharmawardhane SF.
    Neoplasia; 2007 Feb 01; 9(2):147-58. PubMed ID: 17356711
    [Abstract] [Full Text] [Related]

  • 23. Entinostat Converts Immune-Resistant Breast and Pancreatic Cancers into Checkpoint-Responsive Tumors by Reprogramming Tumor-Infiltrating MDSCs.
    Christmas BJ, Rafie CI, Hopkins AC, Scott BA, Ma HS, Cruz KA, Woolman S, Armstrong TD, Connolly RM, Azad NA, Jaffee EM, Roussos Torres ET.
    Cancer Immunol Res; 2018 Dec 01; 6(12):1561-1577. PubMed ID: 30341213
    [Abstract] [Full Text] [Related]

  • 24. Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167 in Mice by Supercritical Fluid Chromatography-Tandem Mass Spectrometry.
    Maldonado MDM, Rosado-González G, Bloom J, Duconge J, Ruiz-Calderón JF, Hernández-O'Farrill E, Vlaar C, Rodríguez-Orengo JF, Dharmawardhane S.
    ACS Omega; 2019 Nov 05; 4(19):17981-17989. PubMed ID: 31720502
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Targeting Rac and Cdc42 GTPases in Cancer.
    Maldonado MDM, Dharmawardhane S.
    Cancer Res; 2018 Jun 15; 78(12):3101-3111. PubMed ID: 29858187
    [Abstract] [Full Text] [Related]

  • 32. Targeting dermatophyte Cdc42 and Rac GTPase signaling to hinder hyphal elongation and virulence.
    Ishii M, Matsumoto Y, Yamada T, Uga H, Katada T, Ohata S.
    iScience; 2024 Jun 21; 27(6):110139. PubMed ID: 38952678
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Temporally and spatially coordinated roles for Rho, Rac, Cdc42 and their effectors in growth cone guidance by a physiological electric field.
    Rajnicek AM, Foubister LE, McCaig CD.
    J Cell Sci; 2006 May 01; 119(Pt 9):1723-35. PubMed ID: 16595546
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Inhibition of protein prenylation by bisphosphonates causes sustained activation of Rac, Cdc42, and Rho GTPases.
    Dunford JE, Rogers MJ, Ebetino FH, Phipps RJ, Coxon FP.
    J Bone Miner Res; 2006 May 01; 21(5):684-94. PubMed ID: 16734383
    [Abstract] [Full Text] [Related]

  • 39. A Rac1/Cdc42 GTPase-specific small molecule inhibitor suppresses growth of primary human prostate cancer xenografts and prolongs survival in mice.
    Zins K, Lucas T, Reichl P, Abraham D, Aharinejad S.
    PLoS One; 2013 May 01; 8(9):e74924. PubMed ID: 24040362
    [Abstract] [Full Text] [Related]

  • 40. Inhibition of Rac activity alleviates lipopolysaccharide-induced acute pulmonary injury in mice.
    Yao HY, Chen L, Xu C, Wang J, Chen J, Xie QM, Wu X, Yan XF.
    Biochim Biophys Acta; 2011 Jul 01; 1810(7):666-74. PubMed ID: 21511011
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.